Tidal Royalty Inc. has announced its entry into a binding letter of intent with MichiCann Medical Inc. with respect to the acquisition of all of the issued shares of MichiCann. After completion of the proposed transaction, the shareholders of Tidal will hold approximately 20% of the issued common shares of the resulting issuer, and the former shareholders of MichiCann will hold approximately 80% of the resulting issuer shares, on a fully-diluted basis.
The Company's shares will remain halted until the Canadian Securities Exchange has reviewed and approved the Proposed Transaction and has determined it appropriateness to lift the halt on trading in respect of the securities.
"This represents a first step to become an MSO (Multi-State-Operator). The MSO model is due for a significant shift in approach. We feel that investors are already moving past the traditional MSO models to MSO 2.0. In our view, investors are looking for not just a presence in multiple states, but instead a meaningful presence in the markets that MSO's serve. The incoming team with RWB has in recent recorded history qualified itself as adept at achieving this by the following industry leading and pioneering achievements such as growing and standardizing strains at scale, something unprecedented post prohibition cannabis segment; creating branding and distribution around growers and growing methodologies that have proven to truly resonate with consumers of all stripes - existing cannabis users and first-time cannabis users; and proven ability to build profitable businesses while achieving growth rates that are usually only achieved by companies that sacrifice profits for revenue growth." says Theo van der Linde, Chief Financial Officer of Tidal
For more information: 
Tidal Royalty Corporation
161 Bay St., Suite 4010
tidalroyalty.com
[email protected]
